摘要
目的比较国产阿卡波糖胶囊剂与进口片剂治疗2型糖尿病的经济效果。方法采用药物经济学原理对2种方案进行成本-效果分析。结果与治疗前比较,用药4wk及8wk后2组空腹血糖(FBG)及餐后血糖(2hPBG)水平均下降(P>005);用药8wk后2组糖化血红蛋白(HbA1c)均有明显下降(P<005)。治疗组成本-效果比低于对照组。结论国产阿卡波糖胶囊剂治疗2型糖尿病的疗效与其进口片剂相当,但经济效果优于进口片剂。
Objective To compare the cost-effectiveness between domestic acarbose capsule and imported acarbose tablet in the treatment of type 2 diabetic mellitus.Methods Principle of pharmacoeconomics was adopted to analyze the cost - effectiveness of the 2 therapies.Results After 4 weeks and 8 weeks of treatment, fasting blood glucose （FBG） and postprandial blood glucose （PBG） decreased in both study groups （P〉0.05）. After 8 weeks of treatment, HbAlc decreased significantly in both study groups （P〈0.05）. The costeffectiveness ratio （C/E） of domestic group was lower than imported group.Conclusion Efficacies of domestic acarbose capsule in the treatment of type 2 diabetic mellitus was the same as imported acarbose tablet. But the cost-effectiveness of domestic acarbose capsule was better than imported acarbose tablet.
出处
《中国实用医药》
2006年第1期21-23,共3页
China Practical Medicine
关键词
阿卡波糖
2型糖尿病
成本-效果分析
acarbose： type 2 diabetic mellitus： cost-effectiveness analysis
